Hiroaki Ueno

Chief Executive Officer at MITSUBISHI TANABE PHARMA CORPORATION

65 year

Health Technology

Commercial Services

Profile

Presently, Hiroaki Ueno is President & Representative Director at Mitsubishi Tanabe Pharma Corp. He is also on the board of The Kaiteki Institute, Inc.

Hiroaki Ueno active positions

Companies	Position	Start
MITSUBISHI TANABE PHARMA CORPORATION	Chief Executive Officer	2007-09-30
The Kaiteki Institute, Inc. The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan.	Director/Board Member	-

All active positions of Hiroaki Ueno

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hiroaki Ueno's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Mitsubishi Tanabe Pharma Corp. Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.	Health Technology
The Kaiteki Institute, Inc. The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan.	Commercial Services